vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and Primoris Services Corp (PRIM). Click either name above to swap in a different company.
Primoris Services Corp is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× PERRIGO Co plc). Primoris Services Corp runs the higher net margin — 2.8% vs -127.8%, a 130.6% gap on every dollar of revenue. On growth, Primoris Services Corp posted the faster year-over-year revenue change (6.7% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $121.1M). Over the past eight quarters, Primoris Services Corp's revenue compounded faster (14.7% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Primoris Services Corporation is a publicly traded specialty construction and infrastructure company based in the United States, with a particular focus on pipelines for natural gas, wastewater and water. As of 2014 it was a Fortune 1000 company.
PRGO vs PRIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.9B |
| Net Profit | $-1.4B | $51.7M |
| Gross Margin | 32.6% | 9.4% |
| Operating Margin | -116.0% | 4.2% |
| Net Margin | -127.8% | 2.8% |
| Revenue YoY | -2.5% | 6.7% |
| Net Profit YoY | -3093.9% | -4.2% |
| EPS (diluted) | $-10.23 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.0B | $2.2B | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.0B | $1.6B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.1B | $1.4B |
| Q4 25 | $-1.4B | $51.7M | ||
| Q3 25 | $7.5M | $94.6M | ||
| Q2 25 | $-8.4M | $84.3M | ||
| Q1 25 | $-6.4M | $44.2M | ||
| Q4 24 | $-44.4M | $54.0M | ||
| Q3 24 | $-21.0M | $58.4M | ||
| Q2 24 | $-108.4M | $49.5M | ||
| Q1 24 | $2.0M | $18.9M |
| Q4 25 | 32.6% | 9.4% | ||
| Q3 25 | 36.1% | 10.8% | ||
| Q2 25 | 34.4% | 12.3% | ||
| Q1 25 | 37.6% | 10.4% | ||
| Q4 24 | 33.9% | 10.6% | ||
| Q3 24 | 37.2% | 12.0% | ||
| Q2 24 | 37.0% | 11.9% | ||
| Q1 24 | 33.1% | 9.4% |
| Q4 25 | -116.0% | 4.2% | ||
| Q3 25 | 7.0% | 6.3% | ||
| Q2 25 | 4.3% | 6.7% | ||
| Q1 25 | 4.5% | 4.3% | ||
| Q4 24 | 10.0% | 5.0% | ||
| Q3 24 | 7.4% | 6.0% | ||
| Q2 24 | -2.5% | 5.5% | ||
| Q1 24 | -5.1% | 3.1% |
| Q4 25 | -127.8% | 2.8% | ||
| Q3 25 | 0.7% | 4.3% | ||
| Q2 25 | -0.8% | 4.5% | ||
| Q1 25 | -0.6% | 2.7% | ||
| Q4 24 | -3.9% | 3.1% | ||
| Q3 24 | -1.9% | 3.5% | ||
| Q2 24 | -10.2% | 3.2% | ||
| Q1 24 | 0.2% | 1.3% |
| Q4 25 | $-10.23 | $0.94 | ||
| Q3 25 | $0.05 | $1.73 | ||
| Q2 25 | $-0.06 | $1.54 | ||
| Q1 25 | $-0.05 | $0.81 | ||
| Q4 24 | $-0.32 | $0.98 | ||
| Q3 24 | $-0.15 | $1.07 | ||
| Q2 24 | $-0.79 | $0.91 | ||
| Q1 24 | $0.01 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $535.5M |
| Total DebtLower is stronger | — | $469.9M |
| Stockholders' EquityBook value | $2.9B | $1.7B |
| Total Assets | $8.5B | $4.4B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $535.5M | ||
| Q3 25 | $432.1M | $431.4M | ||
| Q2 25 | $454.2M | $390.3M | ||
| Q1 25 | $409.9M | $351.6M | ||
| Q4 24 | $558.8M | $455.8M | ||
| Q3 24 | $1.5B | $352.7M | ||
| Q2 24 | $542.8M | $207.4M | ||
| Q1 24 | $658.5M | $177.6M |
| Q4 25 | — | $469.9M | ||
| Q3 25 | — | $486.0M | ||
| Q2 25 | — | $603.1M | ||
| Q1 25 | — | $612.0M | ||
| Q4 24 | — | $734.8M | ||
| Q3 24 | — | $903.7M | ||
| Q2 24 | — | $933.0M | ||
| Q1 24 | — | $951.7M |
| Q4 25 | $2.9B | $1.7B | ||
| Q3 25 | $4.4B | $1.6B | ||
| Q2 25 | $4.5B | $1.5B | ||
| Q1 25 | $4.4B | $1.4B | ||
| Q4 24 | $4.3B | $1.4B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | $4.5B | $1.3B | ||
| Q1 24 | $4.7B | $1.2B |
| Q4 25 | $8.5B | $4.4B | ||
| Q3 25 | $10.1B | $4.6B | ||
| Q2 25 | $10.1B | $4.5B | ||
| Q1 25 | $9.8B | $4.2B | ||
| Q4 24 | $9.6B | $4.2B | ||
| Q3 24 | $11.2B | $4.2B | ||
| Q2 24 | $10.4B | $4.0B | ||
| Q1 24 | $10.6B | $4.0B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.39× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $142.9M |
| Free Cash FlowOCF − Capex | $148.6M | $121.1M |
| FCF MarginFCF / Revenue | 13.4% | 6.5% |
| Capex IntensityCapex / Revenue | 2.4% | 1.2% |
| Cash ConversionOCF / Net Profit | — | 2.76× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $340.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $142.9M | ||
| Q3 25 | $51.7M | $182.9M | ||
| Q2 25 | $75.9M | $78.5M | ||
| Q1 25 | $-64.5M | $66.2M | ||
| Q4 24 | $312.6M | $298.3M | ||
| Q3 24 | $42.2M | $222.5M | ||
| Q2 24 | $9.5M | $16.1M | ||
| Q1 24 | $-1.4M | $-28.5M |
| Q4 25 | $148.6M | $121.1M | ||
| Q3 25 | $29.8M | $148.4M | ||
| Q2 25 | $56.7M | $45.3M | ||
| Q1 25 | $-90.0M | $25.6M | ||
| Q4 24 | $274.9M | $270.0M | ||
| Q3 24 | $15.1M | $158.8M | ||
| Q2 24 | $-18.9M | $-8.1M | ||
| Q1 24 | $-26.5M | $-38.9M |
| Q4 25 | 13.4% | 6.5% | ||
| Q3 25 | 2.9% | 6.8% | ||
| Q2 25 | 5.4% | 2.4% | ||
| Q1 25 | -8.6% | 1.6% | ||
| Q4 24 | 24.2% | 15.5% | ||
| Q3 24 | 1.4% | 9.6% | ||
| Q2 24 | -1.8% | -0.5% | ||
| Q1 24 | -2.4% | -2.8% |
| Q4 25 | 2.4% | 1.2% | ||
| Q3 25 | 2.1% | 1.6% | ||
| Q2 25 | 1.8% | 1.8% | ||
| Q1 25 | 2.4% | 2.5% | ||
| Q4 24 | 3.3% | 1.6% | ||
| Q3 24 | 2.5% | 3.9% | ||
| Q2 24 | 2.7% | 1.5% | ||
| Q1 24 | 2.3% | 0.7% |
| Q4 25 | — | 2.76× | ||
| Q3 25 | 6.89× | 1.93× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 5.53× | ||
| Q3 24 | — | 3.81× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | -0.70× | -1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
PRIM
| Energy Segment | $1.2B | 64% |
| Unit Price Contracts | $473.7M | 25% |
| Cost Reimbursable Contracts | $121.3M | 7% |
| Other | $74.9M | 4% |
